Published Oct 16, 2026
| Aspect | Seqera Platform | LatchBio | DNAnexus Platform |
|---|---|---|---|
| Starting Price | Published plan names are available, but enterprise tier pricing and list prices were not clearly visible in accessible materials; enterprise/GxP offerings are likely quote-based. | Credit-based pricing model with publicly shared examples; enterprise discounts referenced. | Pricing is provided via formalized rate documentation for some offerings; enterprise engagements are typically contractual. |
| Recommended for | Organizations standardized on Nextflow that require orchestration, governance, and scalable execution across cloud/HPC. | Teams seeking a web-native, data-centric UX with a credits-based billing model. | Large-scale genomics programs, consortia, and regulated contexts that require a hosted, full-stack environment. |
| Key Strength | Deep integration with the Nextflow ecosystem and enterprise controls (SSO/SCIM/audit logs). | Publicly surfaced pricing examples and emphasis on data views/visualization. | Established presence in large genomics initiatives and documented pricing information for some offerings. |
| Key Weakness | Price transparency during evaluation can be a concern; value is context-dependent and tied to Nextflow adoption. | Not always a direct replacement for Nextflow-native workflows; platform fit varies by use case. | Some users perceive hosted platforms as adding limited incremental value over CLI+HPC for certain workflows. |
Pricing comparison notes
Direct competitors and differentiators
Market share and adoption trends